30.07.2015 Views

Impacts-of-methamphetamine-in-Victoria-Community-Assessment-Penington-Institute

Impacts-of-methamphetamine-in-Victoria-Community-Assessment-Penington-Institute

Impacts-of-methamphetamine-in-Victoria-Community-Assessment-Penington-Institute

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Family relationshipsMethamphetam<strong>in</strong>e use by children, sibl<strong>in</strong>gs or parents can be damag<strong>in</strong>g to families, impact<strong>in</strong>g on<strong>in</strong>ternal and external family relationships. While sometimes challeng<strong>in</strong>g, ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g <strong>in</strong>ternalrelationships is important, as families can support the <strong>in</strong>dividual to make safer choices about their<strong>methamphetam<strong>in</strong>e</strong> use [34]. US research also <strong>in</strong>dicates that connectedness to family is a protectivefactor aga<strong>in</strong>st drug use among young people [63].External relationships are also important <strong>in</strong> assist<strong>in</strong>g families to deal with <strong>methamphetam<strong>in</strong>e</strong> use.Research with Australian families found that families with children us<strong>in</strong>g drugs felt a lack <strong>of</strong> supportfrom the wider community [64]. This can result <strong>in</strong> isolation and exclusion <strong>of</strong> people us<strong>in</strong>g<strong>methamphetam<strong>in</strong>e</strong> and their families at a time when they are at their most vulnerable and <strong>in</strong> mostneed.Families are also at risk when a parent uses <strong>methamphetam<strong>in</strong>e</strong>. Most obviously, children areparticularly vulnerable <strong>in</strong> this situation. Drug <strong>in</strong>toxication and withdrawal can result <strong>in</strong> reduced abilityto care for children and engagement <strong>in</strong> the illicit drug market can expose children to violence andillegal activities [65]. Psychological effects associated with the use <strong>of</strong> <strong>methamphetam<strong>in</strong>e</strong> such asdepression, anxiety and psychosis are not conducive to good parent<strong>in</strong>g and may impact on thewellbe<strong>in</strong>g <strong>of</strong> children. Importantly, parental illicit drug use is <strong>of</strong>ten part <strong>of</strong> a more complex picture <strong>of</strong>disadvantage, <strong>in</strong>clud<strong>in</strong>g poverty, and social isolation [65]. This suggests that a multifaceted approachto parental drug use is required.TreatmentAustralian researchers have written that “specialised treatment options for <strong>methamphetam<strong>in</strong>e</strong> use <strong>in</strong>Australia are scarce, a picture that is not dissimilar to most other parts <strong>of</strong> the world” [66]. Further,writ<strong>in</strong>g <strong>in</strong> “Pr<strong>in</strong>ciples <strong>of</strong> Addiction”, McKet<strong>in</strong> and colleagues have stated that “despite the extent <strong>of</strong><strong>methamphetam<strong>in</strong>e</strong> use, and result<strong>in</strong>g harms, no specialized treatment options for this drug have beenproved to be effective” [4]. There are various form <strong>of</strong> non-specialist treatment available for<strong>methamphetam<strong>in</strong>e</strong> use, <strong>in</strong>clud<strong>in</strong>g counsell<strong>in</strong>g, outpatient and <strong>in</strong>patient detoxification and residentialrehabilitation.National treatment data from the Australian <strong>Institute</strong> <strong>of</strong> Health and Welfare provide an <strong>in</strong>dication <strong>of</strong>levels <strong>of</strong> treatment seek<strong>in</strong>g for <strong>methamphetam<strong>in</strong>e</strong> use. Treatment is measured by completed episodes<strong>of</strong> care, so does not measure cases were people start but do not f<strong>in</strong>ish treatment. Recent data<strong>in</strong>dicate that amphetam<strong>in</strong>es (<strong>in</strong>clud<strong>in</strong>g <strong>methamphetam<strong>in</strong>e</strong>) were the fourth most common pr<strong>in</strong>cipaldrug <strong>of</strong> concern for which treatment was sought <strong>in</strong> 2010–11 (n<strong>in</strong>e per cent <strong>of</strong> episodes). This is aslight <strong>in</strong>crease compared with 2009–10 (seven per cent) [17]. However, consistent with research thatf<strong>in</strong>ds <strong>methamphetam<strong>in</strong>e</strong> is typically used concurrently with other drugs [66] when amphetam<strong>in</strong>e usereported <strong>in</strong> treatment episodes for other pr<strong>in</strong>cipal drugs <strong>of</strong> concern was <strong>in</strong>cluded, 19 per cent <strong>of</strong> alltreatment episodes dur<strong>in</strong>g 2010-2011 <strong>in</strong>volved amphetam<strong>in</strong>es. Similar to previous years, counsell<strong>in</strong>gwas the most common ma<strong>in</strong> treatment type, with about half (48 per cent) <strong>of</strong> episodes whereamphetam<strong>in</strong>es were the pr<strong>in</strong>cipal drug <strong>of</strong> concern report<strong>in</strong>g this treatment [17].Treatment outcomes for <strong>methamphetam<strong>in</strong>e</strong> use have been found to be time-limited, <strong>in</strong> that thebenefits are apparent only dur<strong>in</strong>g the <strong>in</strong>dividual’s time <strong>in</strong> treatment [67]. These f<strong>in</strong>d<strong>in</strong>gs highlight thechronic relaps<strong>in</strong>g nature <strong>of</strong> <strong>methamphetam<strong>in</strong>e</strong> dependence and the need for a treatment approachwith a more susta<strong>in</strong>ed impact [67].18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!